当前位置:首页 - 行情中心 - 康泰医学(300869) - 财务分析 - 现金流量表

康泰医学

(300869)

  

流通市值:44.41亿  总市值:70.44亿
流通股本:2.53亿   总股本:4.02亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金232,338,810.43125,886,621.02491,576,488.76344,951,997.27
  收到的税费返还5,543,420.954,454,714.926,320,508.236,670,849.87
  收到其他与经营活动有关的现金11,060,774.326,641,199.0828,399,583.8311,210,927.67
  经营活动现金流入小计248,943,005.7136,982,535.02526,296,580.82362,833,774.81
  购买商品、接受劳务支付的现金81,881,272.8641,095,929.38120,318,419.6491,109,422.34
  支付给职工以及为职工支付的现金84,973,934.1941,875,623.95185,056,347.55137,993,734.06
  支付的各项税费10,183,845.014,243,316.6547,005,510.639,173,430.22
  支付其他与经营活动有关的现金46,008,502.4819,819,821.5111,573,724.2159,364,182.96
  经营活动现金流出小计223,047,554.54107,034,691.48463,954,002327,640,769.58
  经营活动产生的现金流量净额25,895,451.1629,947,843.5462,342,578.8235,193,005.23
二、投资活动产生的现金流量:
  收回投资收到的现金230,000,0002,117,852,634.845,250,064,143.61,683,728,000
  取得投资收益收到的现金11,087,403.345,901,591.18118,076,646.8297,261,221.84
  处置固定资产、无形资产和其他长期资产收回的现金净额--947,103.01362,000
  收到的其他与投资活动有关的现金2,265,405,327.8630,000,000-2,596,539,999.44
  投资活动现金流入小计2,506,492,731.22,153,754,226.025,369,087,893.434,377,891,221.28
  购建固定资产、无形资产和其他长期资产支付的现金22,949,291.245,030,122.7254,460,712.5337,134,862.88
  投资支付的现金700,000,0002,167,741,055.885,150,304,023.841,625,000,000
  支付其他与投资活动有关的现金1,770,409,523.84-270,000,0002,307,441,109.58
  投资活动现金流出小计2,493,358,815.082,172,771,178.65,474,764,736.373,969,575,972.46
  投资活动产生的现金流量净额13,133,916.12-19,016,952.58-105,676,842.94408,315,248.82
三、筹资活动产生的现金流量:
  取得借款收到的现金165,000,00031,436,896.3790,000,00090,000,000
  收到其他与筹资活动有关的现金22,010,00022,010,000673,187,600-
  筹资活动现金流入小计187,010,00053,446,896.37763,187,60090,000,000
  偿还债务支付的现金60,000,000-377,000,000347,000,000
  分配股利、利润或偿付利息支付的现金101,568,436480,483.33127,716,768.46128,308,971.47
  支付其他与筹资活动有关的现金9,519,302.1482,710.982,209,831.261,373,831.3
  筹资活动现金流出小计171,087,738.1963,194.31506,926,599.72476,682,802.77
  筹资活动产生的现金流量净额15,922,261.952,483,702.06256,261,000.28-386,682,802.77
四、汇率变动对现金及现金等价物的影响-1,792,124.01-339,893.734,157,788.59-5,475,666.14
五、现金及现金等价物净增加额53,159,505.1763,074,699.29217,084,524.7551,349,785.14
  加:期初现金及现金等价物余额684,307,771.48684,307,771.48467,223,246.73467,223,246.73
  期末现金及现金等价物余额737,467,276.65747,382,470.77684,307,771.48518,573,031.87
补充资料:
  净利润16,937,573.17--77,902,564.68-
  资产减值准备16,022,591.5-109,445,716.65-
  固定资产和投资性房地产折旧11,631,377.86-23,634,386.18-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧9,612,176.19-22,178,035.08-
    投资性房地产折旧2,019,201.67-1,456,351.1-
  无形资产摊销1,179,849.12-2,353,178.8-
  长期待摊费用摊销40,943.76-15,844.08-
  递延收益摊销-393,676.33--1,395,476.07-
  处置固定资产、无形资产和其他长期资产的损失11,244.08-88,681.75-
  固定资产报废损失0---
  公允价值变动损失-2,752,724.31--1,588,083.19-
  财务费用4,117,441.13--2,805,002.07-
  投资损失-849,480.1--22,518,834.81-
  递延所得税-1,393,102.02-2,171,474.51-
  其中:递延所得税资产减少-1,298,322.66-2,025,191.54-
    递延所得税负债增加-94,779.36-146,282.97-
  存货的减少-21,974,341.72-74,032,834.19-
  经营性应收项目的减少-7,860,342--13,877,282.67-
  经营性应付项目的增加10,329,532.41--33,092,145.64-
  其他--0-
  现金的期末余额737,467,276.65-684,307,771.48-
  减:现金的期初余额684,307,771.48---
  减:现金等价物的期初余额--467,223,246.73-
  现金及现金等价物的净增加额53,159,505.17-217,084,524.75-
公告日期2025-08-292025-04-292025-04-292024-10-28
审计意见(境内)标准无保留意见
TOP↑